You are here

Prilenia Therapeutics

Four more drugs in keenly watched ALS trial miss the mark

Pharmaphorum

Tue, 02/18/25 - 09:52 am

clinical trials

Prilenia Therapeutics

Clene Nanomedicine

Huntington’s disease R&D is regaining ground after several disappointments

Pharma Voice

Mon, 09/9/24 - 10:44 am

Huntington's disease

Prilenia Therapeutics

Ionis Pharmaceuticals

Vico Therapeutics

Companies to Watch: 12 Late-Stage Contenders in Neurodegenerative Disease

BioSpace

Mon, 07/24/23 - 09:57 am

neurodegenerative disease

Alzheimer's disease

Axsome Therapeutics

BrainStorm Cell Therapeutics

Seelos Therapeutics

Parkinson's Disease

Mitsubishi Tanabe Pharma

Huntington's disease

Prilenia Therapeutics

Prilenia searches for positive signs as oral ALS drug fails to improve disease severity in phase 2

Fierce Biotech

Fri, 02/24/23 - 09:25 am

Prilenia Therapeutics

Prilenia hopes to buck the Huntington’s trend

EP Vantage

Thu, 04/1/21 - 10:45 am

Prilenia Therapeutics

Huntington's disease

First-of-its-kind trial in ALS spurs hope for brutal disease

BioPharma Dive

Wed, 09/25/19 - 11:35 pm

clinical trials

Implicit Bioscience

Prilenia Therapeutics

Clene Nanomedicine